![]() |
SOPHiA GENETICS SA (SOPH): Business Model Canvas [Jan-2025 Updated]
CH | Healthcare | Medical - Healthcare Information Services | NASDAQ
|

- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
SOPHiA GENETICS SA (SOPH) Bundle
In the rapidly evolving landscape of precision medicine, SOPHiA GENETICS SA (SOPH) emerges as a groundbreaking innovator, transforming genomic data analysis through cutting-edge artificial intelligence. By seamlessly integrating advanced machine learning algorithms with complex medical diagnostics, the company is revolutionizing how healthcare professionals interpret genetic information, offering unprecedented insights that promise to redefine personalized medical treatment across oncology, clinical diagnostics, and genetic research.
SOPHiA GENETICS SA (SOPH) - Business Model: Key Partnerships
Collaboration with Healthcare Institutions and Research Centers
SOPHiA GENETICS has established partnerships with the following healthcare institutions:
Institution | Partnership Details | Year Established |
---|---|---|
Massachusetts General Hospital | Genomic data analysis collaboration | 2019 |
Mayo Clinic | AI-driven diagnostic research | 2020 |
University Hospital Zurich | Precision medicine research | 2018 |
Strategic Partnerships with Medical Technology and Diagnostic Companies
Key strategic technology partnerships include:
- Illumina Inc. - Genomic sequencing technology integration
- Thermo Fisher Scientific - Diagnostic platform collaboration
- QIAGEN N.V. - Molecular diagnostics partnership
Academic and Pharmaceutical Research Network Alliances
Academic Institution | Research Focus | Collaboration Value |
---|---|---|
Harvard Medical School | Oncology genomics | $2.3 million research grant |
Stanford University | AI in precision medicine | $1.7 million research funding |
Technology Integration Partners for AI and Genomic Data Analysis
Technology integration partnerships:
- Microsoft Azure - Cloud computing infrastructure
- NVIDIA Corporation - AI computational hardware
- Google Cloud Platform - Machine learning integration
Total Partnership Network Reach: Over 500 healthcare and research institutions globally as of 2024.
SOPHiA GENETICS SA (SOPH) - Business Model: Key Activities
Development of AI-powered Genomic Data Analysis Platforms
SOPHiA GENETICS invested €36.4 million in R&D expenses in 2022. The company developed AI-powered platforms across multiple genomic testing domains, including:
- Oncology genomic analysis
- Hereditary disease screening
- Rare disease diagnostics
Platform Capability | Genomic Testing Domains | Annual Analysis Volume |
---|---|---|
SOPHiA DDM Platform | Oncology | Over 1.3 million genomic tests analyzed |
AI Genomic Screening | Rare Diseases | 500,000+ genomic profiles processed |
Clinical Diagnostic Software and Solution Engineering
SOPHiA GENETICS developed cloud-based genomic data analysis solutions with the following specifications:
- 24 CE-IVD marked solutions
- 510(k) clearance from FDA for multiple diagnostic tests
- Integration with 220+ global healthcare institutions
Continuous Research and Innovation in Precision Medicine
Research investment metrics for 2022:
Research Category | Investment Amount | Research Focus |
---|---|---|
Precision Medicine R&D | €36.4 million | Advanced genomic interpretation algorithms |
AI Technology Development | €12.7 million | Machine learning genomic analysis |
Data Management and Computational Genomics
SOPHiA GENETICS manages extensive genomic datasets with:
- Over 1.5 petabytes of genomic data processed
- Cloud-based secure data storage infrastructure
- Advanced computational genomics algorithms
Regulatory Compliance and Clinical Validation Processes
Regulatory compliance achievements include:
Regulatory Standard | Compliance Status | Certification Year |
---|---|---|
CE-IVD Marking | 24 approved diagnostic solutions | 2022 |
FDA 510(k) Clearance | Multiple diagnostic test approvals | 2022-2023 |
SOPHiA GENETICS SA (SOPH) - Business Model: Key Resources
Advanced AI and Machine Learning Algorithms
As of 2024, SOPHiA GENETICS has developed proprietary AI algorithms specifically designed for genomic data analysis.
AI Technology Metric | Value |
---|---|
Machine Learning Models | 17 specialized genomic interpretation models |
AI Processing Capacity | Over 1.2 million genomic data samples processed annually |
Computational Accuracy | 98.7% precision in genetic variant identification |
Proprietary Genomic Data Analysis Technology
SOPHiA GENETICS maintains a cutting-edge genomic analysis platform.
- Digital Pathology Platform: SOPHiA DDM
- Genomic Data Processing Speed: 250 terabytes per month
- Technology Coverage: 28 different clinical domains
Skilled Multidisciplinary Research and Engineering Teams
Team Composition | Number |
---|---|
Total Research Personnel | 186 employees |
PhD Holders | 72 researchers |
Bioinformatics Specialists | 54 professionals |
Intellectual Property and Patent Portfolio
SOPHiA GENETICS has a robust intellectual property strategy.
IP Category | Quantity |
---|---|
Total Patent Families | 37 registered patents |
Pending Patent Applications | 12 additional applications |
Geographical Patent Coverage | 18 countries |
Cloud-Based Computational Infrastructure
The company leverages advanced cloud computing resources.
- Cloud Storage Capacity: 4.5 petabytes
- Global Data Centers: 3 primary locations
- Computational Processing Power: 680 teraFLOPS
SOPHiA GENETICS SA (SOPH) - Business Model: Value Propositions
Precision Medicine through Advanced Genomic Data Interpretation
SOPHiA GENETICS offers genomic data analysis platform covering 21 clinical areas as of 2023. The platform processes 78,000 genomic tests per month across 1,200 healthcare institutions globally.
Clinical Areas Covered | Monthly Test Volume | Global Healthcare Institutions |
---|---|---|
21 specialized domains | 78,000 genomic tests | 1,200 institutions |
AI-Driven Diagnostic Insights for Personalized Healthcare
SOPHiA's AI technology delivers diagnostic accuracy with the following capabilities:
- 99.5% variant detection precision
- 70% faster analysis compared to traditional methods
- Machine learning algorithms trained on 1.2 million genomic data points
Standardized and Scalable Genomic Analysis Solutions
Solution Type | Scalability Metric | Global Reach |
---|---|---|
Standardized genomic platform | 350% year-over-year growth | 70+ countries |
Improved Clinical Decision-Making Capabilities
SOPHiA provides clinicians with comprehensive genomic insights supporting complex diagnostic processes.
- Supports 21 different clinical specialties
- Reduces diagnostic time by 60%
- Enables precision treatment selection
Reduction of Diagnostic Uncertainty in Complex Genetic Conditions
The platform delivers advanced genetic analysis with high accuracy and comprehensive reporting.
Diagnostic Accuracy | Genetic Condition Coverage | Clinical Impact |
---|---|---|
99.5% variant detection | 500+ genetic conditions | Significant diagnostic confidence improvement |
SOPHiA GENETICS SA (SOPH) - Business Model: Customer Relationships
Direct Sales and Support for Healthcare Professionals
SOPHiA GENETICS maintains a dedicated sales team targeting healthcare institutions with 416 total customers as of 2022, including 237 active customers across 52 countries.
Customer Segment | Number of Institutions |
---|---|
Hospitals | 184 |
Research Centers | 127 |
Diagnostic Laboratories | 105 |
Continuous Technical and Clinical Training
SOPHiA GENETICS invests in comprehensive training programs with:
- 42 dedicated training sessions in 2022
- Over 1,200 healthcare professionals trained annually
- Online and in-person training modules
Online Knowledge Sharing Platforms
Digital platforms include:
- SOPHiA DDM platform with 99.5% uptime
- Web-based training resources
- Collaborative genomic data analysis tools
Customer Success Management Programs
Program Component | Details |
---|---|
Dedicated Account Managers | 37 customer success professionals |
Average Customer Retention Rate | 85.6% |
Customer Satisfaction Score | 4.7/5 |
Collaborative Research and Development Engagement
SOPHiA GENETICS collaborates with 78 research institutions globally, with:
- 23 active joint research projects
- €4.2 million invested in collaborative R&D initiatives
- Shared genomic data repositories
SOPHiA GENETICS SA (SOPH) - Business Model: Channels
Direct Sales Team Targeting Hospitals and Clinical Laboratories
SOPHiA GENETICS maintains a dedicated direct sales force targeting healthcare institutions globally. As of 2023, the company reported 159 employees in sales and marketing functions.
Region | Number of Sales Representatives | Target Healthcare Institutions |
---|---|---|
Europe | 42 | Specialized Cancer Centers |
North America | 38 | Academic Medical Centers |
Asia-Pacific | 25 | Research Hospitals |
Online Digital Platform and Web-Based Solutions
SOPHiA GENETICS offers a cloud-based AI platform for genomic data analysis.
- Platform Name: SOPHiA DDM™ Platform
- Active Users in 2023: Over 1,000 healthcare institutions
- Geographical Coverage: 70+ countries
Medical Conferences and Industry Exhibitions
The company actively participates in international genomics and precision medicine events.
Conference Type | Annual Participation | Estimated Audience Reach |
---|---|---|
Oncology Conferences | 12-15 events | 5,000+ healthcare professionals |
Genomics Symposiums | 8-10 events | 3,500+ researchers |
Scientific Publications and Academic Presentations
SOPHiA GENETICS maintains strong academic credibility through research publications.
- Peer-Reviewed Publications in 2023: 22 scientific papers
- Citation Index: 150+ academic citations
- Research Collaboration Partners: 45 academic institutions
Partner Referral Networks
The company leverages strategic partnerships to expand its market reach.
Partner Category | Number of Partners | Collaboration Focus |
---|---|---|
Technology Partners | 18 | AI and Genomic Technology Integration |
Healthcare Network Partners | 62 | Clinical Data Sharing and Research |
Pharmaceutical Collaborators | 27 | Precision Medicine Research |
SOPHiA GENETICS SA (SOPH) - Business Model: Customer Segments
Oncology Research Centers
SOPHiA GENETICS serves 378 oncology research centers globally as of 2023.
Region | Number of Oncology Research Centers | Penetration Rate |
---|---|---|
North America | 142 | 37.6% |
Europe | 186 | 49.2% |
Asia-Pacific | 50 | 13.2% |
Clinical Diagnostic Laboratories
SOPHiA GENETICS collaborates with 512 clinical diagnostic laboratories worldwide in 2024.
- Average annual contract value: $187,000
- Diagnostic testing volume: 68,400 genetic tests per year
Hospitals and Healthcare Institutions
The company serves 246 hospital networks across 32 countries.
Healthcare Segment | Number of Institutions | Average Annual Spend |
---|---|---|
Academic Medical Centers | 87 | $425,000 |
Community Hospitals | 159 | $156,000 |
Pharmaceutical Research Organizations
SOPHiA GENETICS partners with 94 pharmaceutical research organizations in 2024.
- Collaboration rate: 67% in oncology research
- Total research projects: 216
- Average project value: $350,000
Genetic Testing and Precision Medicine Specialists
The company supports 263 specialized genetic testing centers globally.
Specialization Area | Number of Centers | Market Coverage |
---|---|---|
Oncology Precision Medicine | 142 | 54% |
Rare Disease Diagnostics | 81 | 31% |
Hereditary Cancer Testing | 40 | 15% |
SOPHiA GENETICS SA (SOPH) - Business Model: Cost Structure
Research and Development Investments
For the fiscal year 2022, SOPHiA GENETICS reported R&D expenses of CHF 49.7 million, representing approximately 62% of total operating expenses.
Year | R&D Expenses (CHF) | Percentage of Operating Expenses |
---|---|---|
2022 | 49.7 million | 62% |
2021 | 44.3 million | 58% |
Technology Infrastructure Maintenance
Annual technology infrastructure costs estimated at CHF 12-15 million, including cloud computing, data storage, and network maintenance.
- Cloud computing infrastructure: CHF 5.2 million
- Data storage solutions: CHF 3.8 million
- Network maintenance: CHF 3.5 million
Talent Acquisition and Retention
Personnel expenses for 2022 totaled CHF 58.4 million, covering salaries, benefits, and recruitment costs.
Expense Category | Amount (CHF) |
---|---|
Salaries | 45.6 million |
Employee Benefits | 8.2 million |
Recruitment Costs | 4.6 million |
Regulatory Compliance Expenses
Estimated annual regulatory compliance costs: CHF 7.5 million, covering medical device certifications and healthcare data regulations.
- Medical device certification: CHF 3.2 million
- Data privacy compliance: CHF 2.5 million
- Legal and consulting fees: CHF 1.8 million
Marketing and Sales Operations
Marketing and sales expenses for 2022 reached CHF 33.2 million, representing 41% of total operating expenses.
Marketing Expense Category | Amount (CHF) |
---|---|
Sales Team Compensation | 18.6 million |
Digital Marketing | 7.4 million |
Conference and Event Marketing | 4.2 million |
Marketing Technology | 3.0 million |
SOPHiA GENETICS SA (SOPH) - Business Model: Revenue Streams
Software Licensing and Subscription Models
SOPHiA GENETICS generates revenue through its AI-powered genomic data analysis platform. In 2022, the company reported software licensing revenues of $36.4 million.
Revenue Type | 2022 Amount | Percentage of Total Revenue |
---|---|---|
Software Licensing | $36.4 million | 62.3% |
Subscription Services | $12.8 million | 21.9% |
Professional Services and Consulting
The company offers specialized genomic data analysis consulting services. In 2022, professional services generated $5.2 million in revenue.
Data Analysis Platform Fees
SOPHiA GENETICS charges fees for access to its advanced genomic data analysis platform. Platform fees in 2022 reached $7.6 million.
Training and Certification Programs
- Genomic data analysis training programs
- Professional certification courses
- 2022 training revenue: $2.1 million
Strategic Partnership Collaborations
Collaborative partnerships with healthcare and research institutions contribute to revenue streams. Strategic partnership revenues in 2022 totaled $4.9 million.
Partner Type | 2022 Collaboration Revenue |
---|---|
Healthcare Institutions | $3.2 million |
Research Organizations | $1.7 million |
Total company revenue for 2022: $58.5 million
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.